DRKS00004553已完成未知
A randomised, double-blind, placebo-controlled study of oral immunotherapy in peanut allergic children - Peanut OIT
Klinik für Pädiatrie mit Schwerpunkt Pneumologie und ImmunologieUniversitätsmedizin Charité Berlin- CVK0 个研究点目标入组 61 人开始时间: 2013年7月31日最近更新:
适应症
试验速览
- 阶段
- 未知
- 状态
- 已完成
- 发起方
- 入组人数
- 61
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
- 分配方式
- Randomized controlled study
- 盲法
- Blinded (masking used)
入排标准
- 年龄范围
- 3 Years 至 18 Years（—）
- 性别
- All
入选标准
- •Children with
- •1. a sensitization against peanut (peanut-specific IgE > 0.35 kU/l)
- •2. challenge-proven clinical relevant peanut allergy
- •3. signed informed consent by the mother and father of the child
- •4. mother or father being mentally as well as verbally capable of understanding the
- •proposed intention and intervention of the study
排除标准
- •Children with
- •1. ongoing treatment of another form of immunotherapy (e.g. systemic or sublingual
- •immunotherapy against pollen) during the study period
- •2. participation in another interventional study trial
- •3. other severe diseases (following the clinical judgement of the study physician)
研究者
相似试验
已完成
不适用
A randomised, double-blind, placebo-controlled study evaluating Palmitoylethanolamide for diabetic-related peripheral neuropathic pain, inflammation and quality of lifediabetic-related peripheral neuropathyMetabolic and Endocrine - DiabetesNeurological - Other neurological disordersACTRN12620001302943Gencor Pacific Ltd70
进行中（未招募）
1 期
Intravenous imatinib for corona virus-related lung injury.EUCTR2020-005447-23-NLAmsterdam Universitair Medische Centra, location VUmc90
进行中（未招募）
1 期
Study to evaluate the micro-macroscopic effects on muscles, the safety and tolerability, and the efficacy of givinostat in patients with Becker Muscular DystrophyEUCTR2017-001629-41-NLITALFARMACO S.P.A.48
进行中（未招募）
1 期
Clinical trial to study the safety and tolerability of EP395 in comparison with placebo in patients with chronic obstructive pulmonary disease (COPD)Chronic obstructive pulmonary disease (COPD)MedDRA version: 21.1Level: LLTClassification code 10010952Term: COPDSystem Organ Class: 100000004855EUCTR2021-005787-22-DEEpiEndo Pharmaceuticals60
进行中（未招募）
1 期
A study to test a potential new treatment for COPD patients suffering from the common cold or influenza.Patients with Chronic Obstructive Pulmonary Disease (COPD). In part 1 of the study the patients are in stable state. In part 2 of the study patients have a respiratory virus infection (i.e. cold or flu virus).MedDRA version: 21.1 Level: LLT Classification code 10010953 Term: COPD exacerbation System Organ Class: 100000004855EUCTR2017-003679-75-GBSynairgen Research Limited130